Profile Photo

Warnings, Recalls, Approvals

  • Public Group
  • 2 days, 8 hours ago
  • 15.6K

    Members

Chiesi Global Rare Diseases Announces FDA Approval of Ferriprox (deferiprone) for Treatment of Transfusional Iron Overload due to Sickle Cell Disease

Home Forums Consumer Warnings & Recalls Chiesi Global Rare Diseases Announces FDA Approval of Ferriprox (deferiprone) for Treatment of Transfusional Iron Overload due to Sickle Cell Disease

This topic contains 1 voice and has 0 replies.
1 voice
0 replies
  • Author
    Posts
    • #34394
      cfields
      Keymaster

      Chiesi Global Rare Diseases Announces FDA Approval of Ferriprox (deferiprone) for Treatment of Transfusional Iron Overload due to Sickle Cell Disease

You must be logged in to reply to this topic.

Want more Hive80?

You must create an account to continue browsing.
It’s quick, free, and members get unlimited access to Hive80.
Ask questions, follow topics, join hives, make friends, and be a part of the community!

Sign Up Now

Want more Hive80?

You must create an account to continue browsing.
It’s quick, free, and members get unlimited access to Hive80.
Ask questions, follow topics, join hives, make friends, and be a part of the community!

Sign Up Now